Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

25,720 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7,363
Recruiting: 3,965
Ph III recruiting: 535
Growth YoY: +10.3%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3,404)

clinicaltrialsPublishedShowing 351–386 of 386 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01438437	Trial of Ablation of Small Hepatocellular Carcinomas in Patients of Cirrhosis	unknown	Phase 4	54	All India Institute of Medical SciencesOTHER	1	Jul 13, 2012	clinicaltrials
NCT00803907	Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma(Imiquimod)	unknown	Phase 4	20	University of Sao PauloOTHER	1	Jun 13, 2012	clinicaltrials